Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003)

ClinicalTrials.gov ID: NCT04053387

Public ClinicalTrials.gov record NCT04053387. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 1:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Long-Term, Open-Label, Extension Study to Evaluate the Safety and Efficacy of Tapinarof Cream, 1% for the Treatment of Plaque Psoriasis in Adults

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a long-term, open-label, multicenter, study to evaluate the safety and efficacy of topical tapinarof cream, 1% in adults with plaque psoriasis. Subjects in this study completed treatment in 1 of 2 Phase 3 pivotal efficacy and safety studies (Study DMVT-505-3001 or Study DMVT-505-3002). This study will consist of up to 40 weeks of treatment and a 4-week safety follow-up period.

Study identification

NCT ID
NCT04053387
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Organon and Co
Industry
Enrollment
763 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 13, 2019 (Actual)
Primary completion
Apr 6, 2021 (Actual)
Completion
Apr 6, 2021 (Actual)
Last update posted
Aug 6, 2025

2019 – 2021

United States locations

U.S. sites
85
U.S. states
34
U.S. cities
77
Facility City State ZIP Site status
Dermavant Investigative Site Birmingham Alabama 35205 —
Dermavant Investigative Site Phoenix Arizona 85032 —
Dermavant Investigative Site Bryant Arkansas 72022 —
Dermavant Investigative Site Fort Smith Arkansas 72916 —
Dermavant Investigative Site Fountain Valley California 92708 —
Dermavant Investigative Site Fremont California 94538 —
Dermavant Investigative Site Fresno California 93720 —
Dermavant Investigative Site Los Angeles California 90033 —
Dermavant Investigative Site Los Angeles California 90045 —
Dermavant Investigative Site Northridge California 91324 —
Dermavant Investigative Site Oceanside California 92056 —
Dermavant Investigative Site San Diego California 92123 —
Dermavant Investigative Site Santa Ana California 92701 —
Dermavant Investigative Site Santa Monica California 90404 —
Dermavant Investigative Site Denver Colorado 80210 —
Dermavant Investigative Site Cromwell Connecticut 06416 —
Dermavant Investigative Site Boca Raton Florida 33431 —
Dermavant Investigative Site Boynton Beach Florida 33437 —
Dermavant Investigative Site Hialeah Florida 33016 —
Dermavant Investigative Site Margate Florida 33063 —
Dermavant Investigative Site Miami Florida 33144 —
Dermavant Investigative Site Miramar Florida 33027 —
Dermavant Investigative Site Boise Idaho 83713 —
Dermavant Investigative Site Rolling Meadows Illinois 60008 —
Dermavant Investigative Site Evansville Indiana 47714 —
Dermavant Investigative Site Indianapolis Indiana 46250 —
Dermavant Investigative Site New Albany Indiana 47150 —
Dermavant Investigative Site Plainfield Indiana 46168 —
Dermavant Investigative Site Overland Park Kansas 66215 —
Dermavant Investigative Site Louisville Kentucky 40217 —
Dermavant Investigative Site Owensboro Kentucky 42303 —
Dermavant Investigative Site Baton Rouge Louisiana 70809 —
Dermavant Investigative Site New Orleans Louisiana 70115 —
Dermavant Investigative Site Rockville Maryland 20850 —
Dermavant Investigative Site Boston Massachusetts 02115 —
Dermavant Investigative Site Bay City Michigan 48706 —
Dermavant Investigative Site Clarkston Michigan 48346 —
Dermavant Clinical Site Detroit Michigan 48202 —
Dermavant Investigational Site Detroit Michigan 48202 —
Dermavant Investigative Site Fort Gratiot Michigan 48059 —
Dermavant Investigative Site Warren Michigan 48088 —
Dermavant Investigative Site Fridley Minnesota 55432 —
Dermavant Investigative Site Saint Joseph Missouri 64506 —
Dermavant Investigative Site Omaha Nebraska 68144 —
Dermavant Clinical Site Las Vegas Nevada 89148 —
Dermavant Investigative Site Las Vegas Nevada 89148 —
Dermavant Investigative Site East Windsor New Jersey 08520 —
Dermavant Investigative Site Hackensack New Jersey 07601 —
Dermavant Investigative Site Verona New Jersey 07044 —
Dermavant Clinical Site Brooklyn New York 11203 —
Dermavant Investigative Site Kew Gardens New York 11374 —
Dermavant Investigative Site New York New York 10029 —
Dermavant Investigative Site Rochester New York 14623 —
Dermavant Investigative Site Stony Brook New York 11790 —
Dermavant Clinical Site Watertown New York 13601 —
Dermavant Investigative Site Cary North Carolina 27518 —
Dermavant Investigative Site High Point North Carolina 27262 —
Dermavant Investigative Site Wilmington North Carolina 28405 —
Dermavant Investigative Site Winston-Salem North Carolina 27157 —
Dermavant Investigative Site Beachwood Ohio 44122 —
Dermavant Investigative Site Bexley Ohio 43209 —
Dermavant Investigative Site Norman Oklahoma 73071 —
Dermavant Investigate Site Norman Oklahoma 73072 —
Dermavant Investigative Site Norman Oklahoma 73072 —
Dermavant Clinical Site Gresham Oregon 97030 —
Dermavant Investigative Site Portland Oregon 97210 —
Dermavant Investigative Site Portland Oregon 97223 —
Dermavant Investigative Site Pittsburgh Pennsylvania 15213 —
Dermavant Investigative Site Johnston Rhode Island 02919 —
Dermavant Investigative Site Charleston South Carolina 29407 —
Dermavant Investigative Site Nashville Tennessee 37215 —
Dermavant Investigative Site Arlington Texas 76011 —
Dermavant Clinical Site Bellaire Texas 77401 —
Dermavant Investigative Site College Station Texas 77845 —
Dermavant Investigative Site Dripping Springs Texas 78620 —
Dermavant Investigative Site Houston Texas 77004 —
Dermavant Clinical Site Houston Texas 77030 —
Dermavant Investigative Site Pflugerville Texas 78660 —
Dermavant Investigative Site Plano Texas 75024 —
Dermavant Investigative Site San Antonio Texas 78213 —
Dermavant Investigative Site San Antonio Texas 78229 —
Dermavant Investigative Site Webster Texas 77598 —
Dermavant Investigative Site West Jordan Utah 84088 —
Dermavant Investigative Site Norfolk Virginia 23502 —
Dermavant Investigative Site Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04053387, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 6, 2025 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04053387 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →